23 studies found for:
Open Studies | "Whooping Cough"
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines
|
||||
2 | Recruiting |
Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals
|
||||
3 | Recruiting |
Survey for Usage Rates of Pertussis Vaccines in the State of Wisconsin
|
||||
4 | Recruiting |
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine as a Booster in Adolescents
|
||||
5 | Recruiting |
Pertussis (Tdap) Vaccination in Pregnancy
|
||||
6 | Not yet recruiting |
Pertussis Infection in Adolescents and Adults With Prolonged Cough
|
||||
7 | Recruiting |
Post Marketing Surveillance for ADACEL™ in South Korea
|
||||
8 | Recruiting |
Regulatory Post-Marketing Surveillance Study for TETRAXIM™
|
||||
9 | Recruiting |
Database Surveillance Safety Study of PENTACEL® Vaccine
|
||||
10 | Not yet recruiting |
Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
|
||||
11 | Recruiting |
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
|
||||
12 | Unknown † |
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
|
||||
13 | Recruiting |
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
|
||||
14 | Recruiting |
Protecting Pregnant Women From Infectious Diseases
|
||||
15 | Recruiting |
Tdap Vaccine in Post-Partum Women
|
||||
16 | Unknown † |
Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
|
||||
17 | Recruiting |
Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers
|
||||
18 | Not yet recruiting |
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' BoostrixTM Vaccine in Previously Boosted Young Adults
|
||||
19 | Not yet recruiting |
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
|
||||
20 | Recruiting |
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age
|
† Indicates status has not been verified in more than two years